| Ingredient | Strength | Functional Role |
|---|---|---|
| Dalbergia sissoo extract | 600 mg | Promotes Osteoblastic Activity and Down regulates Osteoclastic Activity |
| Calcium citrate-malate | 1,200 mg | a well-absorbed calcium salt used to supply elemental calcium for bone mineralization (form is generally better absorbed than calcium carbonate, and performs better when gastric acidity is low). |
| Vitamin D₃ (cholecalciferol) | 400 IU | supports intestinal calcium absorption and normal bone remodelling. |
| Magnesium | 100 mg | co-factor for bone formation and for enzymes that regulate vitamin D and parathyroid hormone; contributes to bone mineral structure. |
| Zinc | 7.5 mg | required for osteoblast activity, inhibits osteoclastogenesis in some models; supports bone repair and matrix synthesis. |
| Boron | 1.5 mg | trace element that influences calcium, magnesium and vitamin D metabolism and may support bone density. |
A multi-ingredient bone support tablet combining Dalbergia sissoo plus key minerals and vitamin D to:
improve/maintain mineral supply for bone (calcium, magnesium, zinc, boron),
support calcium absorption (vitamin D₃), and
potentially provide additional osteogenic stimulus from the standardized Dalbergia sissoo extract (supported by preclinical and small clinical/standardized-extract reports). Use is as a supplement for people with osteoporosis or at risk of low bone mass — ideally under a clinician’s supervision.
Primary indication (as written): dietary adjunct to support bone mineralization and to help maintain bone health in patients with osteoporosis.
Typical use cases: complement dietary calcium/vitamin D; support bone remodelling in postmenopausal osteoporosis or age-related bone loss when used with standard medical therapy and lifestyle measures (exercise, fall prevention). (Note: supplements should not replace prescription osteoporosis treatments when those are indicated.)
Dalbergia sissoo: Promotes Osteoblastic Activity and Down regulates Osteoclastic Activity
Calcium citrate-malate: supplies calcium in a highly soluble form; supports hydroxyapatite formation in bone and is efficiently absorbed even when gastric acidity is reduced. Adequate calcium intake is required to slow bone loss and support bone mineral density.
Vitamin D₃: increases intestinal absorption of calcium and phosphate, maintains serum mineral levels needed for normal bone mineralization and lowers risk of osteomalacia; adequate vitamin D also reduces falls/fracture risk when used at effective doses.
Magnesium: required for proper bone crystal formation and affects PTH and vitamin D metabolism; deficiency is associated with poorer bone microarchitecture.
Zinc: supports osteoblast function and matrix synthesis and may inhibit pathways that lead to bone resorption.
Boron: appears to enhance utilization of calcium, magnesium and vitamin D and influence oestrogen / testosterone metabolism, which can be relevant in postmenopausal bone loss.
These effects generally resolve upon continued use or dose adjustment.
Store below 25°C in a cool, dry, and dark place.
Protect from moisture.
Keep out of reach of children.
This information is provided for educational purposes only.
Tovex Tablets must be consumed strictly under the guidance of your doctor or healthcare professional.
Do not change, start, or stop any prescribed medication without consulting your physician.